Genexine Market Cap

Genexine has a market cap or net worth of 182.60 billion as of April 1, 2025. Its market cap has decreased by -44.59% in one year.

Market Cap

182.60B

Enterprise Value

198.77B

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,015.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 182.60B, an increase of 67.49%. That is a compound annual growth rate of 3.37%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	181.24B	-25.37%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	3,069.93B	106.72%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	38.03T
ALTEOGEN	18.79T
Yuhan	8,537.79B
SK Biopharmaceuticals	7,893.98B
HLB Co., Ltd.	7,500.72B
Sam Chun Dang Pharm.	3,930.51B
PharmaResearch	3,506.51B

Market Cap Rankings